Epidemiology of Systemic Sclerosis in a Large US Managed Care Population

REFERENCES

1. 1.↵
   1. Chizzolini C

   . Update on pathophysiology of scleroderma with special reference to immunoinflammatory events. Ann Med 2007;39:42–53.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Yamamoto T

   . Scleroderma — pathophysiology. Eur J Dermatol 2009;19:14–24.

   OpenUrlPubMed
3. 3.↵
   1. Gabrielli A,
   2. Avvedimento EV,
   3. Krieg T

   . Scleroderma. N Engl J Med 2009;360:1989–2003.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. LeRoy EC,
   2. Black C,
   3. Fleischmajer R,
   4. Jablonska S,
   5. Krieg T,
   6. Medsger TA Jr.,
   7. et al.

   Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202–5.

   OpenUrlPubMed
5. 5.↵
   1. Ranque B,
   2. Mouthon L

   . Geoepidemiology of systemic sclerosis. Autoimmun Rev 2010;9:A311–8.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Medsger TA Jr.,
   2. Masi AT,
   3. Rodnan GP,
   4. Benedek TG,
   5. Robinson H

   . Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369–76.

   OpenUrlPubMed
7. 7.↵
   1. Steen VD,
   2. Oddis CV,
   3. Conte CG,
   4. Janoski J,
   5. Casterline GZ,
   6. Medsger TA Jr.

   . Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982. Arthritis Rheum 1997;40:441–5.

   OpenUrlPubMed
8. 8.↵
   1. Mayes MD,
   2. Lacey JV Jr.,
   3. Beebe-Dimmer J,
   4. Gillespie BW,
   5. Cooper B,
   6. Laing TJ,
   7. et al.

   Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246–55.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Robinson D Jr.,
   2. Eisenberg D,
   3. Nietert PJ,
   4. Doyle M,
   5. Bala M,
   6. Paramore C,
   7. et al.

   Systemic sclerosis prevalence and comorbidities in the US, 2001–2002. Curr Med Res Opin 2008;24:1157–66.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Maricq HR,
    2. Weinrich MC,
    3. Keil JE,
    4. Smith EA,
    5. Harper FE,
    6. Nussbaum AI,
    7. et al.

    Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989;32:998–1006.

    OpenUrlCrossRefPubMed